Real-time enrollment status for this macular degeneration clinical trial
Current Status
Active, Not Recruiting
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT06664502 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 92 participants |
| Active Locations | 26 sites in the US |
| Sponsor | EyeBiotech Ltd. |
| Last Updated on CT.gov | March 18, 2026 (Mar 18, 2026) |
As of April 18, 2026: Clinical trial NCT06664502 is currently active_not_recruiting participants. This clinical trial study for macular degeneration is not currently accepting new participants at 26 locations across the United States. The study is sponsored by EyeBiotech Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06664502 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06664502 was last updated Mar 18, 2026 (March 18, 2026). HelloStudys verifies this status automatically.